Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ADENOVIRUS - ANVISA Registration 80254180245

Access comprehensive regulatory information for ADENOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180245 and manufactured by OXOID (ELY) LIMITED.. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, NOVATEC IMMUNDIAGNOSTICA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80254180245
Registration Details
ANVISA Registration Number: 80254180245
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

IMAGEN ADENOVIRUS
Risk Class II

Registration Details

80254180245

25351151397201706

04930429000139

Company Information

England (United Kingdom)
PT: INGLATERRA (REINO UNIDO)

Dates and Status

Apr 24, 2017

VIGENTE

09/18/2025 19:00:01